NCT03223610
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Diffuse Large B-cell Lymphoma, +17 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Clinical trial condition
Lymphoproliferative Disorders
Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.
10,146 public trials
2,034 recruiting studies
Lymphoproliferative Disorders trial results
NCT02693535
- Conditions
- Advanced Solid Tumors, Blood Protein Disorders, Cardiovascular Diseases, +16 more
- Locations
-
- University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States
- Cancer Treatment Centers of America-Phoenix Phoenix, Arizona, United States
- Sutter Auburn Auburn, California, United States
- Sutter Alta Bates Berkeley, California, United States
Recruiting
18F-Fluciclovine PET/CT in Multiple Myeloma
NCT06103838
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Recruiting
PMCF Study Fortilink-TC Ti
NCT07834931
- Conditions
- Bone Diseases, Degenerative Disc Disease Lumbar, Hemic and Lymphatic Diseases, +16 more
- Locations
-
- Hospital Vithas de la Milagrosa Madrid, Spain
- Hospital Universitario Vithas Madrid Aravaca Moncloa-Aravaca, Madrid, Spain
Recruiting
PMCF Study Fortilink-TS Ti
NCT07834736
- Conditions
- Bone Diseases, Degenerative Disc Disease Lumbar, Hemic and Lymphatic Diseases, +16 more
- Locations
-
- Clinica Santa Elena Madrid, Spain
- Centro Médico Asturias Oviedo, Principality of Asturias, Spain
NCT06029309
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- University of Miami Miami, Florida, United States
Recruiting
Carfilzomib Based Chemotherapy Mobilization for Autologous Stem Cell Transplants in Multiple Myeloma
NCT03909412
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Hackensack Meridian Health - John Theurer Cancer Center Hackensack, New Jersey, United States
Recruiting
Open-label of Loncastuximab Tesirine (ADCT-402) in Relapsed/Refractory Marginal Zone Lymphoma
NCT05296070
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- City of Hope National Medical Center Duarte, California, United States
- University of Miami Miami, Florida, United States
- Emory University Atlanta, Georgia, United States
- Vanderbilt University Nashvile, Tennessee, United States
NCT06997081
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- University of Miami Miami, Florida, United States
NCT04935684
- Conditions
- Acute Leukemia in Remission, Bone Marrow Diseases, Chronic Disease, +27 more
- Locations
-
- Service d'Hématologie Clinique et Thérapie Cellulaire CHU Amiens Picardie - Site Sud Amiens, France
- Service Maladies du sang CHU Angers Angers, France
- Hématologie clinique CHU Besançon Besançon, France
- Plateforme d'Investigation Clinique / Centre d'Investigation Clinique - Inserm 1405, CHU Gabriel Montpied Clermont-Ferrand Clermont-Ferrand, France